NFG
IRWD icon

Next Financial Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Next Financial Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-40
Closed – – 2582
2020
Q4 		$0 Buy
+40
New +$438 ﹤0.01% 2377
2017
Q4 		– Sell
-119
Closed -$2K – 811
2017
Q3 		$2K Hold
119
– – ﹤0.01% 1602
2017
Q2 		$2K Hold
119
– – ﹤0.01% 1733
2017
Q1 		$2K Hold
119
– – ﹤0.01% 1703
2016
Q4 		$2K Hold
119
– – ﹤0.01% 2167
2016
Q3 		$2K Hold
119
– – ﹤0.01% 2156
2016
Q2 		$1K Hold
119
– – ﹤0.01% 1664
2016
Q1 		$1K Sell
119
-359
-75% -$2.96K ﹤0.01% 1634
2015
Q4 		$4K Buy
478
+359
+302% +$3.47K ﹤0.01% 1450
2015
Q3 		$1K Buy
+119
New +$1.11K ﹤0.01% 1717

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Next Financial Group's IRWD Position: Q1 2021 in Review

Next Financial Group sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2021, closing a stake of 40 shares.

Next Financial Group first reported a position in IRWD in Q3 2015 and held it in 10 quarters. The position peaked at $4K in Q4 2015. 209 funds tracked by Wall St. Rank hold IRWD as of Q1 2021.

  • Next Financial Group reported no remaining Ironwood Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Next Financial Group sold 40 Ironwood Pharmaceuticals shares in Q1 2021.
  • Next Financial Group first reported a position in Ironwood Pharmaceuticals in Q3 2015 and held it in 10 quarters.
  • Next Financial Group's Ironwood Pharmaceuticals position peaked at $4K in Q4 2015.
  • 209 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2021.

Based on Next Financial Group's 13F filing for Q1 2021, filed 16 Apr 2021.